SAM #NOI-CC-OLAO-26-004813

NIH Clinical Center Sole Source Custom Oligos Procurement from Biolegend

NIH Clinical Center is announcing its intent to award a sole source contract for custom oligos to Biolegend. - Sole source procurement for custom oligos required by the PACT team at the Center for Cellular Engineering (CCE) - Oligos are used for single cell copy number analysis with the Tapestri instrument - Supports clinical quality control assays for CAR-T cell products - Biolegend is the only vendor/OEM able to meet the technical requirements - Statutory authority: 41 U.S.C. 253(c)(1) and FAR 6.302-1 (only one responsible source) - No specific part numbers or quantities provided - Custom oligos must be compatible with the Tapestri instrument - Place of performance: NIH Clinical Center, Bethesda, MD

Description

This is a Notice of Intent, not a request for proposal.  The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Biolegend.

Acquisition Description:

Custom Oligios needed by PACT team at CCE to do single cell copy number analysis with Tapestri instrument for CAR-T cell products to support clinical QC assay.

The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-26-004813) by 12:00 PM eastern standard time on 05/08/2026 to: valerie.gregorio@nih.gov.

All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

View original listing